Skip to main content

ADVERTISEMENT

quality of care

Research Reports
03/15/2017
Journal of Clinical Pathways
Pharma Insights
03/15/2017
Jeremy Schafer, PharmD, MBA
All members of the health care community must play a role in antimicrobial stewardship. The payer role is to monitor appropriate antibiotic use, encourage low-cost options, and help to facilitate the transition of...
All members of the health care community must play a role in antimicrobial stewardship. The payer role is to monitor appropriate antibiotic use, encourage low-cost options, and help to facilitate the transition of...
All...
03/15/2017
Journal of Clinical Pathways
Interview
03/15/2017
JCP Editors
Obesity has reached a crisis point in the United States, and is now regularly classified as an epidemic.1 The proportion of obese adults now comprises one-third of the US population, according to data from the...
Obesity has reached a crisis point in the United States, and is now regularly classified as an epidemic.1 The proportion of obese adults now comprises one-third of the US population, according to data from the...
...
03/15/2017
Journal of Clinical Pathways
Conference Coverage
03/15/2017
JCP Editors
Cancer survivors are living longer than ever. Approximately 15.5 million cancer survivors are currently alive in the United States, according to a research report issued by the American Cancer Society—a number...
Cancer survivors are living longer than ever. Approximately 15.5 million cancer survivors are currently alive in the United States, according to a research report issued by the American Cancer Society—a number...
Cancer...
03/15/2017
Journal of Clinical Pathways
Department
03/15/2017
JCP Editors
More than 70% of childhood cancer survivors receiving follow-up treatment expressed interest in meeting with genetic counselors to better understand cancer predisposition, according to a pilot study conducted at a...
More than 70% of childhood cancer survivors receiving follow-up treatment expressed interest in meeting with genetic counselors to better understand cancer predisposition, according to a pilot study conducted at a...
More...
03/15/2017
Journal of Clinical Pathways
Department
03/15/2017
JCP Editors
Greater than one-half of cancer survivors reported experiencing some degree of financial distress following treatment, according to a study conducted by the LIVESTRONG Foundation (Austin, TX). ----- Related...
Greater than one-half of cancer survivors reported experiencing some degree of financial distress following treatment, according to a study conducted by the LIVESTRONG Foundation (Austin, TX). ----- Related...
...
03/15/2017
Journal of Clinical Pathways
Research in Review
03/15/2017
JCP Editors
Hospice referral for patients with advanced cancer continues to vary significantly by individual physician and treatment department, according to research published in Journal of Oncology Practice (published online...
Hospice referral for patients with advanced cancer continues to vary significantly by individual physician and treatment department, according to research published in Journal of Oncology Practice (published online...
...
03/15/2017
Journal of Clinical Pathways
Research in Review
03/07/2017
JCP Editors
Using body composition metrics to determine dosage of anthracyclines-taxane based chemotherapy for patients with breast cancer can reduce treatment-related toxicity, according to a study published in Clinical Cancer...
Using body composition metrics to determine dosage of anthracyclines-taxane based chemotherapy for patients with breast cancer can reduce treatment-related toxicity, according to a study published in Clinical Cancer...
Using...
03/07/2017
Journal of Clinical Pathways
Research in Review
03/06/2017
JCP Editors
High-dose-rate brachytherapy administered in a single treatment may be a safe and effective alternative for patients with non-metastatic prostate cancer, according to a new study. ----- Related Content Surgery...
High-dose-rate brachytherapy administered in a single treatment may be a safe and effective alternative for patients with non-metastatic prostate cancer, according to a new study. ----- Related Content Surgery...
...
03/06/2017
Journal of Clinical Pathways
Research in Review
02/24/2017
JCP Editors
Mutations in the BTK and PLCG2 genes have the potential to be used as a biomarker for relapse of chronic lymphocytic leukemia (CLL) after treatment with ibrutinib, according to a retrospective review published in the...
Mutations in the BTK and PLCG2 genes have the potential to be used as a biomarker for relapse of chronic lymphocytic leukemia (CLL) after treatment with ibrutinib, according to a retrospective review published in the...
...
02/24/2017
Journal of Clinical Pathways